Switch to:
More From Other Websites
Merus Labs International Inc. Announces Deemed Exercise of Special Warrants May 18 2016
Merus Labs International Inc. Announces Deemed Exercise of Special Warrants May 18 2016
Merus Labs reports 2Q loss May 11 2016
Merus Labs reports 2Q loss May 11 2016
Merus Labs Reports Fiscal Q2 2016 Results May 11 2016
Merus Labs Reports Fiscal Q2 2016 Results May 11 2016
March 7, 2016 Merus Completes Acquisition of Surgestone®, Provames®, Tredemine® and... Apr 04 2016
Merus Announces Re-Election of Directors Apr 04 2016
Merus announces re-election of directors Mar 30 2016
Merus announces re-election of directors Mar 30 2016
Merus Completes Acquisition of Surgestone®, Provames®, Tredemine® and Speciafoldine® Rights from... Mar 07 2016
Merus Completes Acquisition of Surgestone®, Provames®, Tredemine® and Speciafoldine® Rights from... Mar 07 2016
Merus Labs International Inc. Announces Closing Of $27 Million Bought Deal Financing Mar 01 2016
Merus Labs International Inc. announces closing of $27 million bought deal financing Mar 01 2016
Merus Announces Inaugural Deal with Sanofi Feb 23 2016
Merus Announces Inaugural Deal with Sanofi Feb 23 2016
Merus announces $27 million bought deal Feb 19 2016
Merus Labs Reports Solid Fiscal Q1 2016 Results Feb 11 2016
Merus Labs Reports Solid Fiscal Q1 2016 Results Feb 11 2016
Merus completes acquisition of Elantan®, Isoket® and Deponit® rights from UCB and announces date... Feb 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK